Search Results 121-130 of 803 for ���������������������������������������������:PC90���

  1. Tau-tubulin kinase 1: Therapeutic target of Alzheimer's disease - Molecular Neurotherapeutics - Mayo Clinic Research

    Mayo Clinic's Molecular Neurotherapeutics Lab cloned a neuron-specific tau kinase from the human brain tissue cDNA library and characterized the role of ...

  2. Tumor Shrinking Nanoparticle used to Fight Cancer and Brain Tumors - Mayo Clinic

    Mayo Clinic and our partners use technologies such as cookies to collect information from your browser to deliver relevant advertising on our site, in emails ...

  3. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the superiority of MD1003 (300 mg/day) over placebo to clinically improve patients with ...

  4. Zebrafish PKD-Targeted Services - Model Systems Core - Mayo Clinic Research

    The Model Systems Core at Mayo Clinic offers zebrafish PKD-targeted services, including small-molecule screening and human sequence variation functional ...

  5. A Study of a Therapeutic DNA Vaccine for Chronic Hepatitis C Virus (HCV) Infection - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer - Mayo Clinic

    This is an open label, multi-center, Phase Ib dose escalation study of BBI608 administered in combination with either FOLFOX6 with and without bevacizumab, or ...

  7. Focus Areas - Phospholipid Signaling in Embryonic Development and Human Diseases: Kun Ling - Mayo Clinic Research

    Mayo Clinic's Phospholipid Signaling in Embryonic Development and Human Diseases Lab led by Kun Ling, Ph.D., studies phosphoinositide species and enzymes in ...

  8. Niemann-Pick Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and effectiveness of N-Acetyl-L-Leucine (IB1001) for the treatment of Niemann-Pick type C disease (NPC).

  9. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    The purpose of this study is to obtain an estimate of the biochemical response rate as determined by CA125 response using the Gynecologic Cancer Intergroup ( ...

  10. A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors - Mayo Clinic

    The purpose of this study is to evaluate the safety, effectiveness and the maximum tolerable dose of PQR309 for the treatment of selected patients who have ...